Basing on the findings reported by Burdelya [43] and Wang [44], we hypothesize knockdown of stat3 in tumor cells could cause a rise in multiple inflammatory mediators and make the tumor cells more immunogenic that result in recruitment of more CD11b-positive cells from peripheral circulation to the tumor site than the control groups. The gene discussed is ITGAM; the disease is neoplasm.